Literature DB >> 15187581

Central injection of botulinum neurotoxins: behavioural effects in mice.

S Luvisetto1, S Marinelli, O Rossetto, C Montecucco, F Pavone.   

Abstract

Strains of Clostridium botulinum produce seven antigenically distinct botulinum neurotoxins (BoNTs) designated as serotypes A-G. All serotypes interfere with neural transmission by blocking the release of acetylcholine in cholinergic neurons. They cleave specific sites on proteins of the SNARE [soluble n-ethylmaleimide-sensitive factor (NSF) attachment protein receptor] complex, which play a key role in neuroexocytosis. This study assessed the behavioural effects due to central administration of BoNTs in mice. CD1 mice were injected intracerebroventricularly (icv) with sub-lethal doses of BoNT/A or /B and their behavioural responses in conditioning of active avoidance, object recognition test and pharmacologically induced locomotor activity were tested. Compared to control mice, BoNT-treated mice showed: (1) a reduced capacity to discriminate a novel object within a familiar environment; (2) an enhanced stimulant effect by scopolamine and a depressant effect by oxotremorine on locomotor activity. In contrast, central injection of BoNTs did not alter active avoidance acquisition. These results suggest an in vivo functional alteration due to the action of BoNTs directly administered into the central nervous system. The present data demonstrate that BoNTs may represent an analytical tool for studying the functional role of cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187581

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

1.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

2.  Tyr682 in the Aβ-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance.

Authors:  Carmela Matrone; Siro Luvisetto; Luca R La Rosa; Robert Tamayev; Annabella Pignataro; Nadia Canu; Li Yang; Alessia P M Barbagallo; Fabrizio Biundo; Franco Lombino; Hui Zheng; Martine Ammassari-Teule; Luciano D'Adamio
Journal:  Aging Cell       Date:  2012-10-12       Impact factor: 9.304

Review 3.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D.

Authors:  S Luvisetto; E Basso; V Petronilli; P Bernardi; M Forte
Journal:  Neuroscience       Date:  2008-06-21       Impact factor: 3.590

5.  Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.

Authors:  Maciej Gasior; Rebecca Tang; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2013-06-14       Impact factor: 4.030

6.  Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model.

Authors:  Alba Finocchiaro; Sara Marinelli; Federica De Angelis; Valentina Vacca; Siro Luvisetto; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2018-03-18       Impact factor: 4.546

Review 7.  Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review.

Authors:  Alexander Hawlitschka; Andreas Wree
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

Review 8.  Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

Review 9.  Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology.

Authors:  Matteo Caleo; Laura Restani
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.